BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19933689)

  • 21. Expression of survivin mRNA associates with apoptosis, proliferation and histologically aggressive features in hepatocellular carcinoma.
    Morinaga S; Nakamura Y; Ishiwa N; Yoshikawa T; Noguchi Y; Yamamoto Y; Rino Y; Imada T; Takanashi Y; Akaike M; Sugimasa Y; Takemiya S
    Oncol Rep; 2004 Dec; 12(6):1189-94. PubMed ID: 15547736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiogenic molecule expression is downregulated in effusions from breast cancer patients.
    Konstantinovsky S; Nielsen S; Vyberg M; Kvalheim G; Nesland JM; Reich R; Davidson B
    Breast Cancer Res Treat; 2005 Nov; 94(1):71-80. PubMed ID: 16142438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
    Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
    Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcription expression and clinical significance of TTF-1 mRNA in pleural effusion of patients with lung cancer.
    Jiang B; Wu GP; Zhao YJ; Wang SC
    Diagn Cytopathol; 2008 Dec; 36(12):849-54. PubMed ID: 18855882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcription expression and clinical significance of vascular endothelial growth factor mRNA and endostatin mRNA in pleural effusions of patients with lung cancer.
    Chen Y; Liang B; Zhao YJ; Wang SC; Fan YB; Wu GP
    Diagn Cytopathol; 2012 Apr; 40(4):287-91. PubMed ID: 22431315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic value of interleukine-6, transforming growth factor-beta 1 and vascular endothelial growth factor in malignant pleural effusions.
    Duysinx BC; Corhay JL; Hubin L; Nguyen D; Henket M; Louis R
    Respir Med; 2008 Dec; 102(12):1708-14. PubMed ID: 18760578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of the survivin gene in prostate cancer: correlation with clinicopathological characteristics, proliferative activity and apoptosis.
    Kishi H; Igawa M; Kikuno N; Yoshino T; Urakami S; Shiina H
    J Urol; 2004 May; 171(5):1855-60. PubMed ID: 15076293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Up-regulation of survivin mRNA might be a marker for non-invasive detection of non-small cell lung cancer rather than for prognosis.
    Warnecke-Eberz U; Baldus SE; Bollschweiler E; Hoelscher AH; Metzger R
    Anticancer Res; 2008; 28(3A):1525-9. PubMed ID: 18630507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse.
    Yie SM; Lou B; Ye SR; Cao M; He X; Li P; Hu K; Rao L; Wu SM; Xiao HB; Gao E
    Ann Surg Oncol; 2008 Nov; 15(11):3073-82. PubMed ID: 18670822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osteopontin is upregulated in malignant and inflammatory pleural effusions.
    Moschos C; Porfiridis I; Psallidas I; Kollintza A; Stathopoulos GT; Papiris SA; Roussos C; Kalomenidis I
    Respirology; 2009 Jul; 14(5):716-22. PubMed ID: 19476604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of cell-free BIRC5 mRNA in effusions and its potential diagnostic value for differentiating malignant and benign effusions.
    Wang T; Qian X; Wang Z; Wang L; Yu L; Ding Y; Liu B
    Int J Cancer; 2009 Oct; 125(8):1921-5. PubMed ID: 19585499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survivin expression in "low-risk" and "high-risk" myelodysplastic syndromes.
    Gianelli U; Fracchiolla NS; Cortelezzi A; Pellegrini C; Savi F; Moro A; Grimoldi MG; Deliliers GL; Coggi G; Bosari S
    Ann Hematol; 2007 Mar; 86(3):185-9. PubMed ID: 17124585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of RT-PCR detection of human mammaglobin for the diagnosis of breast cancer derived pleural effusions.
    Roncella S; Ferro P; Bacigalupo B; Dessanti P; Pronzato P; Franceschini MC; Pratticò L; Carletti AM; Canessa PA; Fontana V; Fais F; Pistillo MP; Fedeli F
    Diagn Mol Pathol; 2008 Mar; 17(1):28-33. PubMed ID: 18303409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of Survivin and Livin in nasopharyngeal carcinoma.
    Xiang Y; Yao H; Wang S; Hong M; He J; Cao S; Min H; Song E; Guo X
    Laryngoscope; 2006 Jan; 116(1):126-30. PubMed ID: 16481824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of survivin correlated with vessel invasion is a marker of poor prognosis in small adenocarcinoma of the lung.
    Ikehara M; Oshita F; Kameda Y; Ito H; Ohgane N; Suzuki R; Saito H; Yamada K; Noda K; Mitsuda A
    Oncol Rep; 2002; 9(4):835-8. PubMed ID: 12066218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated expression level of survivin protein in soft-tissue sarcomas is a strong independent predictor of survival.
    Kappler M; Kotzsch M; Bartel F; Füssel S; Lautenschläger C; Schmidt U; Würl P; Bache M; Schmidt H; Taubert H; Meye A
    Clin Cancer Res; 2003 Mar; 9(3):1098-104. PubMed ID: 12631613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis.
    Kajiwara Y; Yamasaki F; Hama S; Yahara K; Yoshioka H; Sugiyama K; Arita K; Kurisu K
    Cancer; 2003 Feb; 97(4):1077-83. PubMed ID: 12569609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of survivin mRNA in healthy oral mucosa, oral leucoplakia and oral cancer.
    Lodi G; Franchini R; Bez C; Sardella A; Moneghini L; Pellegrini C; Bosari S; Manfredi M; Vescovi P; Carrassi A
    Oral Dis; 2010 Jan; 16(1):61-7. PubMed ID: 19732355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relevance of c-erbB2, PLU-1 and survivin mRNA expression to diagnostic assessment of breast cancer.
    Izawa A; Kobayashi D; Nasu S; Saito K; Moriai R; Asanuma K; Nakamura M; Yagihashi A; Watanabe N
    Anticancer Res; 2002; 22(5):2965-9. PubMed ID: 12530026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis and origin determination of malignant pleural effusions through the use of the breast cancer marker human mammaglobin.
    Roncella S; Ferro P; Franceschini MC; Bacigalupo B; Dessanti P; Sivori M; Carletti AM; Fontana V; Canessa PA; Pistillo MP; Fedeli F
    Diagn Mol Pathol; 2010 Jun; 19(2):92-8. PubMed ID: 20502186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.